HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taher Abbasi Selected Research

butein

3/2011Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taher Abbasi Research Topics

Disease

22Neoplasms (Cancer)
11/2021 - 03/2011
4Multiple Myeloma
01/2019 - 11/2011
3Inflammation (Inflammations)
01/2019 - 09/2013
3Hepatocellular Carcinoma (Hepatoma)
10/2013 - 03/2011
2Glioblastoma (Glioblastoma Multiforme)
11/2020 - 01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2019
1Lung Neoplasms (Lung Cancer)
01/2018
1Squamous Cell Carcinoma of Head and Neck
08/2017
1Glioma (Gliomas)
01/2016
1Carcinoma (Carcinomatosis)
01/2014
1Carcinogenesis
01/2014
1Stomach Neoplasms (Stomach Cancer)
11/2012
1Prostatic Neoplasms (Prostate Cancer)
07/2011
1Neoplasm Metastasis (Metastasis)
07/2011

Drug/Important Bio-Agent (IBA)

3ChemokinesIBA
01/2019 - 10/2013
3CytokinesIBA
01/2019 - 10/2013
3Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2016
3Pharmaceutical PreparationsIBA
06/2016 - 05/2014
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2011 - 03/2011
2Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2019
2Biological ProductsIBA
11/2021 - 01/2014
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2014 - 05/2012
2Protein Kinases (Protein Kinase)IBA
10/2014 - 05/2012
2Transcription Factors (Transcription Factor)IBA
11/2011 - 07/2011
1Temozolomide (Temodar)FDA LinkGeneric
11/2020
1Lenalidomide (CC 5013)FDA Link
01/2019
1Azacitidine (5 Azacytidine)FDA Link
01/2019
1LipopolysaccharidesIBA
01/2019
1LipopeptidesIBA
01/2019
1B7-H1 AntigenIBA
12/2016
1withaferin AIBA
01/2016
1LactonesIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015
1caryophyllene oxideIBA
10/2014
1Volatile Oils (Essential Oils)IBA
10/2014
1SesquiterpenesIBA
10/2014
1Antineoplastic Agents (Antineoplastics)IBA
05/2014
1AlpelisibIBA
04/2014
1Topoisomerase I InhibitorsIBA
01/2014
1Irinotecan (Camptosar)FDA LinkGeneric
01/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2014
1Drug CombinationsIBA
01/2014
1pyrazolanthroneIBA
01/2014
1JNK Mitogen-Activated Protein KinasesIBA
01/2014
1Antimicrobial PeptidesIBA
10/2013
1Emodin (Archin)IBA
10/2013
1ElastinIBA
09/2013
13-methylquercetinIBA
11/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2012
1honokiolIBA
05/2012
1Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA
05/2012
1celastrolIBA
11/2011
1src-Family KinasesIBA
07/2011
1AndrogensIBA
07/2011
1Ursolic AcidIBA
07/2011
1buteinIBA
03/2011

Therapy/Procedure

11Therapeutics
11/2020 - 05/2012
4Immunotherapy
11/2021 - 12/2016
2Precision Medicine
11/2020 - 01/2018
1Radiotherapy
11/2020